Arovella Therapeutics Limited has released a press release.
The path to first patient dosing
Earlier from Arovella Therapeutics
- Clinical manufacturing batch released, first site activated
- Arovella Appoints Acting CEO
- Board Refresh and CEO Resignation
- CLDN18.2 CAR iNKT Cell Preclinical Data Update